Drugs & Targets FDA approves Afinitor for GI or lung neuroendocrine tumors February 26, 2016Vol.42 No.08
Drugs & Targets FDA grants orphan designation to antifungal drug candidate CD101 IV February 12, 2016Vol.42 No.06
Drugs & Targets Mayo Clinic collaborates with Morphotek in triple-negative breast cancer study. February 05, 2016Vol.42 No.05
Drugs & Targets FDA tells Telesta they need another phase III MCNA trial February 05, 2016Vol.42 No.05
Drugs & Targets Venetoclax Receives Third Breakthrough Designation from FDA February 05, 2016Vol.42 No.05
Drugs & Targets Opdivo-Yervoy Combination Granted Accelerated Approval in Metastatic Melanoma February 01, 2016Vol.39 No.01
Drugs & TargetsFree Zepatier approved for treatment of chronic hepatitis C January 29, 2016Vol.42 No.04
